Amneal Pharmaceuticals, Inc 10-Q for FY2020 Q1
Amneal Pharmaceuticals, Inc. (AMRX)
10-Q
2020-05-11
For: 2020-03-31
View Original
Added on
April 06, 2026
About this 10-Q
Amneal Pharmaceuticals, Inc filed this 10-Q on May 11, 2020, covering the quarter ended March 31, 2020 (FY2020 Q1).
Headline figures
Quarter ended March 31, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $498.53M
- up 11.7% from $446.12M a year earlier
- Net income
- $115.07M
- compared with a net loss of $47.88M a year earlier
- Diluted EPS
- $0.78
- compared with -$0.37 a year earlier